Abridge was founded in 2018 with the mission of powering deeper understanding in healthcare. Our AI-powered platform was purpose-built for medical conversations, improving clinical documentation efficiencies while enabling clinicians to focus on what matters most—their patients. Our enterprise-grade technology transforms patient-clinician conversations into structured clinical notes in real-time, with deep EMR integrations. Powered by Linked Evidence and our purpose-built, auditable AI, we are the only company that maps AI-generated summaries to ground truth, helping providers quickly trust and verify the output. As pioneers in generative AI for healthcare, we are setting the industry standards for the responsible deployment of AI across health systems.

Plataforma digital orientada a pacientes y miembros de equipos de salud. Te permite acceder y gestionar tus datos de salud de manera ágil y segura.

Aperiam is building hyperfolding enzymes with deep learning algorithms that understand protein chemistry.

Azitra, Inc. is a preclinical stage biotechnology company harnessing the power of the microbiome to treat skin disease. The company was founded in 2014 by scientists from Yale University and works with world-leading scientists in dermatology, microbiology, and genetic engineering to advance its programs in atopic dermatitis and targeted orphan indications. For more information, visit www.azitrainc.com.

Braid Health is redefining the landscape of healthcare diagnostics with its innovative approach to real-time radiology and medical imaging. By harnessing the power of advanced technology, we provide healthcare professionals with the tools they need to deliver immediate, high-resolution diagnostic results. This not only enhances the patient experience by reducing wait times for critical information but also significantly improves the efficiency of healthcare operations. Our solutions are designed with the end-user in mind, ensuring that they can be seamlessly integrated into existing healthcare workflows without disrupting the delicate ecosystem of patient care. Whether it's for medical or dental applications, Braid Health's imaging technology is versatile and robust, enabling a level of collaboration and communication between healthcare providers that was previously unattainable. At Braid Health, we are driven by a mission to empower healthcare providers and improve patient outcomes.

Bullseye Biosciences is a biotechnology research company that operationalizes cutting-edge directed evolution technology to develop novel therapeutics for cardiometabolic, inflammation, and oncology patients. By leveraging automation and Next Generation Sequencing, they aim to address challenging drivers of human disease, positioning themselves as a leader in the biotherapeutics space. Their world-class team focuses on translating scientific advancements into effective medicines, making them a compelling option for investors interested in innovative healthcare solutions.

Canaery is a neurotechnology and SaaS data company on a mission to introduce the world’s first enhanced working animals and unlock the hidden world of scent. By building a networked database of detectable odors, Canaery can revolutionize border and transportation security, medical screening and health diagnostics, and invasive pest inspections to make a safer, healthier society.

Character Biosciences (formerly Clover Therapeutics) is a precision medicine platform that is unlocking the patterns of age-related diseases in people of diverse backgrounds. Our mission is to use human genetics to understand what drives diseases so we can discover targeted therapies to more effectively treat patients—many of whom lack any treatment options today. Character partners with patients, providers, payers, and scientists to create deeply phenotyped patient cohorts to enable clinical genomic research. Our approach integrates genomics, longitudinal clinical and imaging data, machine learning, and novel experimental approaches to identify the molecular drivers of disease progression and develop innovative targeted medicines.

Checkerspot is a biotechnology company designing materials and ingredients at a molecular level to enable more sustainable and high-performing products. By optimizing microalgae, Checkerspot’s vertically integrated WING™ platform biomanufactures unique oils that replace commodity oils and petroleum-based inputs and improve performance properties in targeted hardgoods, textiles, and personal care products.

Democratizing gene therapy through transformative manufacturing methods.

Creasallis is the Creative Antibody Solutions company. We use our expert knowledge of Structural Biology and Molecular Biology to create more efficacious therapies. We aim to create a second generation of antibody-based medicines based on expert and precision engineering.

Curie.bio is a founder-focused seed-stage venture firm combined with an industry-grade therapeutics accelerator focused on one thing: helping entrepreneurial founders launch viable therapeutics companies. Curie.bio does this by giving founders access to a team of the world’s best drug hunters and drug makers, seed capital, and best-of-breed services - everything a founder needs to get from concept to a compelling quality dataset that enables an awesome Series A financing. In a nutshell, we want founders in control of their own company and focused on their area of expertise and creativity, while we help make the rest happen smoothly.